[Activity of pyridine-2-aldoxime methiodide (PAM) after oral administration of toxic doses of organophosphorus compounds].
D000818:Animals; D005260:Female; D008297:Male; D051379:Mice; D010758:Phosphorus / Q000633:toxicity*; D011220:Pralidoxime Compounds / Q000494:pharmacology*
D011220:Pralidoxime Compounds; D010758:Phosphorus
Działanie metylojodku pirydyno-2-aldoksymu (PAM) przy doustnym podawaniu toksycznych dawek zwiazków fosforoorganicznych.